jun quan ng, nabil ajwad abu yazida, shing cheng tanc, mastura monif, tin wui wonge, si-yuen lee .  (2025).  extracellular vesicles as delivery vehicles and therapeutic agents for glioblastoma treatment: a systematic review of in vitro and in vivo preclinical studies.  - asian journal of pharmaceutical sciences.  1 - 20. 

mohamad ayub khan sharzehan, hilary sito, md asiful islam, rahman jamal and shing cheng tan.  (2025).  nod2 polymorphisms and their association with colorectal cancer risk: an updated systematic review and meta-analysis.  - cancers.  1 - 21. 

li, kaimin; tan, shing cheng; yang, zhihao; li, chenwei.  (2024).  fas gene expression, prognostic significance and molecular interactions in lung cancer.  - frontiers in oncology.  1 - 12. 

hashemi m, nadafzadeh n, imani mh, rajabi r, ziaolhagh s, bayanzadeh sd, norouzi r, rafiei r, koohpar zk, raei b, zandieh ma, salimimoghadam s, entezari m, taheriazam a, alexiou a, papadakis m, tan sc.  (2023).  targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches.  - cell communication and signaling.  1-32. 

teck yew low, kok-yong chin, shing cheng tan.  (2023).  on the critical importance of meticulous data extraction for meta-analysis of genetic association study.  - archives of physiology and biochemistry.  1007-1008. 

hilary sito & shing cheng tan.  (2024).  genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer.  - molecular biology reports.  1-25. 

hilary sito, mohamad ayub khan sharzehan, md asiful islam, shing cheng tan.  (2024).  genetic variants associated with response to platinum-based chemotherapy in non-small cell lung cancer patients: a field synopsis and meta-analysis.  - british journal of biomedical science.  1-12. 

shing cheng tan, wen tsin poh, audrey chee hui yong, eng wee chua, der jiun ooi, rozi mahmud, muthukkumaran thiagarajan, johnson stanslas.  (2023).  challenges and strategies for improving access to cancer drugs in malaysia: summary of opinions expressed at the 2nd macr international scientific conference 2022.  - cancer management and research.  851-862. 

eng wee chua, audrey chee hui yong, der jiun ooi, jonathan chee woei lim, jhi biau foo, gopal natesan, sau har lee, yuan seng wu, shing cheng tan, johnson stanslas.  (2023).  a summary of the second macr international scientific conference (2nd msc).  - oncologie.  333-334. 

shing cheng tan.  (2019).  use of arbitrary reference genes may lead to misleading conclusions.  - gynecologic and obstetric investigation.  519-520. 

hashemi, mehrdad; khosroshahi, elaheh mohandesi; daneii, pouria; hassanpoor, aria; eslami, maedeh; koohpar, zeinab khazaei; asadi, saba; zabihi, abbas; jamali, behdokht; ghorbani, amin; nabavi, noushin; memarkashani, mohammad reza; salimimoghadam, shokooh; taheriazam, afshin; tan, shing cheng; entezari, maliheh; farahani, najma; hushmandi, kiavash.  (2025).  emerging roles of circrna-mirna networks in cancer development and therapeutic response.  - non-coding rna research.  98 - 115. 

jun quan ng, nabil ajwad abu yazida, shing cheng tanc, mastura monif, tin wui wonge, si-yuen lee .  (2025).  extracellular vesicles as delivery vehicles and therapeutic agents for glioblastoma treatment: a systematic review of in vitro and in vivo preclinical studies.  - asian journal of pharmaceutical sciences.  1 - 20. 

mohamad ayub khan sharzehan, hilary sito, md asiful islam, rahman jamal and shing cheng tan.  (2025).  nod2 polymorphisms and their association with colorectal cancer risk: an updated systematic review and meta-analysis.  - cancers.  1 - 21. 

muhammad-redha abdullah-zawawi, muhammad irfan abdul jalal, shing cheng tan, loscheni varma, nur alyaa afifah md shahri, mira farzana mohamad mokhtar, ryia illani mohd yunos, nurul syakima ab mutalib, rahman jamal.  (2025).  bioinformatics-driven identification of key non-invasive prognostic biomarkers in hepatocellular carcinoma.  - egyptian journal of medical human genetics.  1 - 16. 

hilary sito & shing cheng tan.  (2024).  genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer.  - molecular biology reports.  1-25. 

m. aiman mohtar, saiful effendi syafruddin, muhammad-redha abdullah-zawawi, muhammad irfan abdul jalal, teck yew low, shing cheng tan.  (2026).  integrated approach to precision oncology.  - interdisciplinary cancer research.  407 - 427. 

muhammad-redha abdullah-zawawi, shing cheng tan, m. aiman mohtar, saiful effendi syafruddin, teck yew low, muhammad irfan abdul jalal.  (2025).  unveiling cancer complexity: machine learning insights into multi-omics data.  - .  51 - 69. 

shing cheng tan, hui-min neoh, mia yang ang, mohamad ayub khan sharzehan, nursyazwani omar, and teck yew low.  (2022).  management of next-generation sequencing in precision medicine.  - translational bioinformatics.  149-176. 

saiful effendi syafruddin, mohamad aimanuddin mohtar, tan shing cheng, nadiah abu, nor aidatulakma abdullah@muda, nurul syakima ab mutalib, chin siok fong, neoh hui min, rahman jamal, nor azian abdul murad.  (2019).  umbi initiatives on colorectal cancer biomarkers discovery.  - .  19-28. 

nurul syakima ab mutalib, tan shing cheng, siti aishah sulaiman, rahman jamal.  (2020).  adakah anda mewarisi gen untuk risiko serangan jantung?.  - .  1. 

tan shing cheng, bong yii bonn, ernest mangantig, mohd sukor su'ait.  (2020).  lembaran fakta penyelidikan covid-19: ciri-ciri pesakit covid-19.  - .  1-3. 

tan shing cheng.  (2019).  ulasan rencana: cara-cara yang berbeza untuk mengurangkan pengambilan minuman bergula.  - .  -. 

tan shing cheng.  (2019).  penggunaan komputer atau teknologi robotik untuk membantu pakar pembedahan dalam menjalankan pembedahan ginekologi.  - .  -. 

tan shing cheng.  (2019).  adakah pemadatan faraj, asid traneksamik, radiologi intervensi atau intervensi lain dapat mengawal pendarahan faraj pada wanita yang menghidapi kanser serviks lanjutan?.  - .  -. 

haizatul umiyah nor azmi, shing cheng tan, nor azila muhammad azami, muhammad irfan abdul jalal, saiful effendi syafruddin, abdul kadir abdul karim, rahana abd rahman, chew kah teik, mohd faizal ahmad, nur azurah abdul ghani, muhammad azrai bin abu, rahman jamal.  (2026).  longitudinal shotgun metagenomic profiling of the vaginal microbiome in pregnant and non-pregnant malaysian women.  - 1st regional confrerence on precision medicine.  . 

shing cheng tan, hilary sito, md enamul kabir talukder, abdus samad, muhammad-redha abdullah-zawawi.  (2026).  clinical significance of cyp1a1 in lung cancer prognosis and therapeutic targeting.  - 1st regional confrerence on precision medicine.  . 

muhammad-redha abdullah-zawawi, atiqah syahira muhamad azuan, nor afiqah-aleng, muhammad asyaari zakaria, loscheni varma, nur alyaa afifah md shahri, shing cheng tan, m. aiman mohtar, woon lee yong and hafiza alauddin.  (2026).  graph cluster approach in identifying novel proteins and significant pathways involved in acute myeloid leukemia.  - 1st regional conference on precision health (rcph).  . 

loscheni varma, muhammad irfan abdul jalal, shing cheng tan, nur alyaa afifah md shahri, amalia natasya saiful amri, rahman jamal & muhammad redha abdullah zawawi.  (2025).  machine learning–driven bioinformatics for prognostic gene biomarker discovery in young-onset colorectal cancer.  - 11th national biology symposium 2025 (sbk2025).  . 

shing cheng tan, kaimin li, zhihao yang, chenwei li.  (2024).  biological and clinical significance of fas gene expression in lung cancer.  - 3rd macr international scientific conference.  .